Article
IP-10 Serum Level in Chronic Hepatitis C Virus Patients: Relation to Fibrosis and Response to Combined Interferon/Ribavirin Therapy.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research - 1 Aug 2015
El Raziky Maissa, Elsharkawy Aisha, Said Salma E, Abdelatty Sahar, El Akel Wafaa, Tantawy Omnia, Gamal Eldeen Hadeel, Mabrouk Mahasen
Abstract excerpt
Despite the appearance of the direct acting antiviral drugs, pegylated interferon/ribavirin (PEG-IFN/RBV) still has a place in the standard of care (SOC) therapy for chronic HCV4. Studies were conducted to find an accurate prediction in response to SOC therapy. Pretreatment serum interferon-γ-inducible protein-10 (IP-10) is an independent predictive factor of sustained virological response (SVR) in HCV1-infected...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
